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Abstract Exenteration of the orbit is a disfiguring and
destructive procedure; it is generally performed for orbital
malignancies and often provides a significant reconstructive
challenge. Our purpose was to evaluate the clinical
indications for orbital exenteration in a tertiary referral
center and to assess the reconstructive options employed. A
retrospective nonrandomized analysis was performed,
selecting all patients undergoing orbital exenteration over
a 5-year period, between January 2005 and January 2010.
Patient demographics, tumor characteristics, and recon-
structive techniques used were evaluated. Twenty patients
with a mean age of 76.5 years underwent total orbital
exenteration. Basal cell carcinoma was the main operative
indication (45%), followed by squamous cell carcinoma
(15%). Reconstructive techniques included cover of the raw
orbital cavity with a temporal muscular flap in all cases
followed with split skin grafting (25%), bilaterally pedicle
V-Y advancement flap (10%) and a fasciocutaneous island
flap of the retroauricular region (65%). Twenty percent of
patients had local complications and all were treated in a
satisfactory fashion. Eyelid skin tumors remain an impor-
tant cause of orbital exenteration. Temporal muscle flap is a
reliable and stable reconstructive solution after orbital
exenteration and additional aid is supplied with skin grafts
or local flaps. This technique ensures a good aesthetic
outcome and better situation for later complementary
treatments and minimal associated donor site morbidity.
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Introduction
Orbital exenteration indicates the removal of all the orbital
contents and the periosteum of the orbital cavity. In the
majority of these, an oncological procedure for the surgical
treatment of a malignant tumor with orbital involvement
(primary malignant tumors or, more frequently, secondary
involvement of the orbit) is performed. Malignancies of the
ocular adnexal area are the most prevalent causes of orbital
exenteration and they include basal cell carcinoma, squamous
cell carcinoma and sebaceous cell carcinoma [1–7]. Other less
common tumors include conjunctival malignant melanoma,
adenoid cystic carcinoma of the lacrimal gland and uveal
melanoma with extrascleral extension. Less commonly,
orbital exenteration can be a palliative procedure (pain
control) or a therapeutic intervention in aggressive and
unresponsive cases of orbital infection (mucormycosis,
cellulitis). Exceptionally, orbital exenteration might be
indicated for local control of recurrent benign tumors [1].
Traditionally, orbit exenteration can be divided into three
types: total, sub-total, and enlarged orbital exenteration as
presented by F. Mouriaux et al., and this classification is
based on the extent of the resection performed [4].
Therefore, cases that included excision of adjacent bone
are defined as extended or enlarged exenteration. When all
orbital contents including the globe and periorbita were
removed, exenteration was classified as total. Subtotal
procedures are those cases in which a partial removal of
orbital tissue with sacrifice of the eye was performed.
Others like Frezzoti et al. propose another classification
which notes the structures preserved [8].
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Reconstruction after such a disfiguring major deformity
results in a very significant challenge. The primary goals of
reconstruction are to allow for detection of recurrent
disease, restoration of boundaries between the orbit and
surrounding cavities, and an acceptable aesthetic outcome
[5]. Depending on the tissue remaining, there are several
reconstructive options available; these range from a simple
skin graft to more complex methods of local flaps up to free
tissue transfer [9–12].
The purpose of this study was to review and evaluate the
clinical indications for total orbital exenteration in a tertiary
referral center, and to assess the reconstructive methods
used and their outcome.
Patients and methods
All exenteration cases were performed at the Portuguese
Oncology Institute of Porto (IPO) over a 5 -year period
(between January of 2005 and January of 2010). During this
period, 223 patients with eyelid skin cancer were referred to
our institute. From this population, 20 patients (9%) under-
went total orbit exenteration. The remaining 203 patients
(91%) were treated by tumor excision with complementary
treatment and eyelid reconstruction when indicated. The
authors performed a retrospective, nonrandomized analysis
of these 20 cases and evaluated patient demographic data,
preoperative diagnosis, tumor type, and location. The duration
of disease, progression, and prior treatment were assessed.
Results
Twenty patients (12 males and 8 females), with a mean age
of 76.5 years (range 46–95 years), underwent total orbital
exenteration. Eighteen patients were Caucasian and two
were Black. All cases corresponded to malignant neoplasm
of the periorbital tissues. None of the cases was a primary
tumor of the orbit or an intraocular tumor. Basal cell
carcinoma of the eyelids was the main preoperative
diagnosis (45%). Other diagnoses responsible for the
remaining 55% of the study population were: squamous
cell carcinoma (25%), Merkel cell carcinoma (15%),
sebaceous cell carcinoma (5%), and malignant melanoma
(10%). The right eye was involved in 55% of the cases. The
primary tumor affected the inner canthus (30%) more often
than the lateral canthus (11%) and the superior eyelid (30%)
with higher frequency than the inferior lid (5%), followed
by the malar region that, in advanced cases, conditioned
orbital and eye adnexal involvement (15%), and both lids
simultaneously (10%). Mean follow-up time until IPO
referral was 7.86 years (range 3 months to 20 years). Five
patients (25%) had already undergone previous surgery,
outside the IPO, relating to the primary lesion which later
progressed to exenteration. The preoperative diagnoses are
summarized in Table 1.
At the beginning of the treatment at our institute, five
patients (25%) had severe visual loss in the affected eye and
the remaining cases had severe extensive disease (65% had
an ulcer and 25% had a growing mass) with ocular and/or
orbital structures (muscle and/or orbital fat) involvement.
All the patients were submitted to surgery less than a
year after their first observation at our institute. The mean
delay time between the diagnosis and the first visit to our
center was 7.86 years. Almost half of the study sample
(45%) was evaluated in less than 12 months after diagnosis,
although most of the patients (55% of the sample) had a
time delay in referral to IPO which ranged from 1 to
20 years, the latter value corresponding to one patient
which fortunately represent, those, less frequent situations
where exenteration was the final stage of several failed
attempts to extirpate the tumor.
Table 1 Location and clinicopathologic classification of the primary tumors of 20 patients who underwent orbital exenteration at the Portuguese
Oncology Institute of Porto














Right (R) Left (L) R L R L R L R L R L
Inner canthus 4 2 – – – – – – – – 4 2
Lower eye lid – 1 – – – – – – – – – 1
Both eyelids – – 1 1 – – – – – – 1 1
Lateral canthus 1 – 1 – – – – – – – 2 –
Malar skin – – 1 1 1 – – – – – 2 1
Upper eyelid 1 – – – – 1 – 1 1 2 2 4
Total (no of patients) 9 5 2 1 3 11 9
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Oncological surgery and reconstruction
All patients underwent subperiosteal removal of the eye and
all orbit contents (11 right and 9 left total exenterations).
Total orbit exenteration was performed in cases of local
invasive tumors when complete excision of the tumor with
free margins was only possible with removal of the eye and
all orbital contents in an attempt to achieve cure.
Surgical technique
Adequate wide margins were the main concern, yet with
preservation of as much normal periocular soft tissue as
possible. When it was necessary, adjacent areas of the
medial canthus, temple, or forehead were included in the
excision site. The skin was incised along mark and
dissection was carried down through the periorbital to
expose the orbital rim. The periorbital lining was mobilized
along all orbital walls toward the orbital apex. When
necessary, a frozen section was used to verify that the
margins or resection are free and clear of neoplasm. The
orbital bone was inspected for suspect bone pitting or other
signs of bone erosion or destruction.
Complete histological excision was achieved in 16
patients (80%). In four cases, with documented positive
margins for malignant tumor, adjuvant therapy, in the form
of orbit radiation was given.
The raw orbital cavity was repaired with a temporal
muscular flap in all cases. The muscle flap was subse-
quently covered with one of three reconstructive options:
full-thickness skin graft in five patients (25%), bilaterally
pedicle V-Y advancement flap in 2 patients (10%), and a
fasciocutaneous island flap of the retroauricular region in
13 patients (65%).
The bilaterally pedicle V-Y advancement flap was
chosen in order to possibly preserve at least part of the
upper eyelid which was used to cover the upper half of the
temporal muscle flap. The advancement flap was utilized
for the lower half of the raw area and the wound was closed
without tension. Because this flap has a reliable vascular
basis of two subcutaneous pedicles that supply blood to the
skin island through subdermal plexus lateral bridges, it was
possible to cover a significant defect. This would not have
been possible with a conventional V-Y flap [13] (Fig. 1).
The retroauricular fasciocutaneous island flap was success-
fully performed in 13 patients (65% of the sample), there was
anastomosis of the frontal branch of the temporal superficial
artery to the corresponding vessel of the opposite side as well
as with the ipsilateral supraorbital and supratrochlear arteries.
The arc of rotation associated with the length of the pedicle
allows its transfer in a one-stage procedure [14].
Complications occurred in 20% of the cases (four patients).
In two cases (one with bilaterally pedicle V-Y advancement
flap reconstruction and the other with a retroauricular
fasciocutaneous island flap), infection and marginal tissue
necrosis were reported and the treatment was local antibiotics
and debridement. Later on, one of the patients developed a
sinus fistula and underwent another surgical intervention (a
cervicofacial flap was performed) with complete success. Two
patients, one with a CBC and the other with a SCC had local
recurrences and underwent local radiotherapy.
There is no report of systemic complications related to
this surgical procedure; however, most of the patients were
elderly and have significant co-morbidities.
The mean duration of hospital stay was 10 days. Most of
the patients (60%) had a short stay of 4 to 5 days. Longer
periods of hospitalization were necessary for those four
patients with the complications reported and for the other
three patients with significant co-morbidities that required
therapy unrelated to the periorbital tumor. Mean follow up
was 2.28 years (range of 0.2 to 5 years)
Discussion
The most common indication for exenteration surgery is the
treatment of epithelial malignancy together with orbital
invasion [1–6]. To deal with this, periorbital tissues are
usually excised to completely remove all potentially
involved tissues. Although a highly disfiguring surgery,
exenteration may provide a cure in cases of local invasive
epithelial tumors such as basal and squamous cell carcino-
mas, this was clearly stated by Simon et al. in their study
where they confirmed that when appropriate negative
Fig. 1 Socket reconstruction
with temporal muscular flap
and bilaterally pedicle V-Y ad-
vancement flap (13 months of
follow up)
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margins are assured, there rate is a low recurrence rate (7–
10%) and a low tumor-related death [1]. Our series
corroborates other published data where the main indication
for exenteration was the treatment of cutaneous malignancy
that was not amenable to local excision without compro-
mising the eye. Irradiation, or other topical treatment
modalities were also used [1–6].
As in most published work, in our experience, the
majority of our patients are elderly Caucasian males [4].
Regarding tumor location, other studies indicate that 80%
to 90% of all malignant tumors situated on the eyelids
affect primarily the inner canthus which corroborates with
our results [5]. According to this study series, the upper lid
and the inner canthus were most affected.
Basal cell carcinoma was responsible for 45% of
exenteration in our sample. Similar results were reported
in several other studies such as the work by Nassab et al. in
which basal cell carcinoma was the main surgical indication
accounting for 53% of all tumors [5].
The second most common malignancy demanding exen-
teration in our series was squamous cell carcinoma (which
accounted for 25% of the cases). Several published works
corroborate our data [4–6] indicating that squamous cell
carcinoma is the second most common malignant neoplasm
of the eyelid (nearly 5% to 10% of all eyelid malignancies).
However, other reports describe squamous cell as the most
prevalent tumor for which exenteration was performed [1, 2].
That might be interpreted as being a consequence of early
diagnosis and treatment of basal cell carcinoma, most likely
because of a high index of suspicion in the early stages and
the introduction of Mohs micrographic surgery. On the other
hand, because of perineural invasion, squamous cell carci-
nomas might require more extensive surgery.
It is estimated that cutaneous malignant melanoma of the
eyelid accounts for about 1% of all eyelid malignancies [5].
In our series, it represented the third largest indication for
surgery (10% of the cases).
Sebaceous gland carcinoma, although relatively rare, is
described as being responsible for about 10% of all eyelid
malignancies with a propensity for the upper eyelid, female
sex, and often affecting adults in the sixth to seventh
decades [5, 7, 15]. We had one male patient with inferior
eyelid involvement in the seventh decade of life, which
accounted for 5% of our cases.
Merkel cell carcinoma of the eyelid is known to be a rare
neoplasm with a predilection for the upper eyelid. In our
sample, we had one case of upper eyelid involvement [16, 17].
All patients underwent immediate local flap reconstruction
with temporalis muscle. There are several different recon-
structive options available. Spontaneous granulation and skin
grafting is the simplest. The main disadvantage of the first
technique is the prolonged healing time with inherent risk of
infection and the socket provided has a thin and fragile
covering (admitting a complete take of the graft, which not
always happens) vulnerable to trauma, with a unsatisfactory
appearance [18]. The ease of clinical examination and
recurrence surveillance is repeatedly pointed as an important
and unique advantage of this technique. However, clinical
monitoring can no longer be a true concern in view of all the
currently available technology (MRI, CT scan) [4, 5]. Thus,
covering the socket with a temporalis muscle flap is, in what
concerns tumor surveillance, as safe as skin grafting [19],
with other additional advantages, such as higher resistance to
infection and radiation therapy. In our series, all patients
underwent immediate reconstruction and we achieved stable
results without major postoperative complications. The
coverage of the muscle flap with one of the three options
described improved the appearance and enhanced the
stability and resistance of the reconstructive procedure.
Traditionally, the choice of this and other local flaps as
reconstructive options is faced with apprehension and
reservation when concerning elderly patients. Our results
show this is a safe and reliable option without additional or
increased complications. Furthermore, the higher resistance
of this type of reconstruction to adjuvant therapies such as
radiotherapy is well known, which assumes a great impact is
what concerns complicated patients with other comorbidities
[2–5, 10].
This work reinforces the importance of early diagnosis,
appropriate treatment as well as careful and regular
monitoring to detect any recurrences and act accordingly.
Temporal flap muscle and cutaneous covering with skin
grafts or local flaps are safe and reliable options with long-
term stability, higher resistance to complementary treat-
ments, and reasonable aesthetic results with minimal
associated donor site morbidity.
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